DIXDC1 Promotes Lymphatic Metastasis and Resistance to Cuproptosis in Bladder Cancer Through Mediating DLAT
Advanced Science · 2026-11 · 13 (63)
DOI: 10.1002/advs.77435 ↗At a glance
Journal article in Advanced Science, published online on 2026-08-27. Written by Hongqiong Li and 17 co-authors. Institution: Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China. Major MEDLINE topics: Cuproptosis, Urinary Bladder Neoplasms, Lymphatic Metastasis, Intracellular Signaling Peptides and Proteins. 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Science and Technology Program of Yunnan, Guangdong Basic and Applied Basic Research Foundation.
Abstract (original language)
Lymph node metastasis (LN) represents a major clinical challenge in bladder cancer (BCa) and is associated with dismal prognosis; however, the underlying molecular drivers remain incompletely understood. Here, we demonstrate that DIX domain‐containing protein 1 (DIXDC1) is significantly upregulated in LN‐metastatic BCa tissues and is associated with unfavorable clinical outcomes. Functionally, DIXDC1 enhances BCa cell migration, invasion, proliferation, and lymph node dissemination in vivo. Mechanistically, DIXDC1 directly binds to dihydrolipoamide S‐acetyltransferase (DLAT), a key enzyme in the tricarboxylic acid cycle and a central effector of cuproptosis. This interaction impedes ubiquitin‐proteasome‐mediated degradation of DLAT, thereby stabilizing DLAT protein levels. Through a DLAT‐dependent pathway, DIXDC1 further augments the mRNA stability of the oncogenes NEK7 and CCNE2 , fueling tumor progression. Importantly, DIXDC1 shields BCa cells from copper‐induced DLAT oligomerization and confers marked resistance to Elesclomol‐Cu (ES‐Cu)‐triggered cuproptosis. Depletion of DIXDC1 profoundly sensitizes tumors to cuproptosis in vivo. Collectively, our study unveils the DIXDC1‐DLAT axis as a pivotal regulator that coordinately drives metastatic progression and suppresses copper‐induced cell death, offering a promising therapeutic target for advanced BCa.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
- Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, People's Republic of China.
- Guangdong Provincial Clinical Research Center for Urological Diseases, Guangzhou, Guangdong, People's Republic of China.
- Department of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, Yunnan, People's Republic of China.
- Department of Pathology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
ORCID profiles: Liang Cheng, Xiaole Lu, Shi Fu, Hongjin Shi, Mingsheng Liu, Yawei Zhang, Xinni Ye, Xu Chen, Haifeng Wang
Funding
- National Natural Science Foundation of China
- Science and Technology Program of Yunnan
- Guangdong Basic and Applied Basic Research Foundation
- Yunnan Provincial Health Commission
- Guangdong Medical Science and Technology Research Program
- Sun Yat-sen Pilot Scientific Research Fund
- External Cooperation Research Project of the Second Affiliated Hospital of Kunming Medical University
- 2025 Graduate Education Innovation Fund of Kunming Medical University
Cite
APA
Li, H., Cheng, L., Lu, X., Dong, H., Fu, S., Shi, H., Liu, M., Yang, C., Huang, Y., Chen, Z., Zhang, Y., Jie, K., Zhang, X., Kui, X., Ye, X., Chen, S., Chen, X., & Wang, H. (2026). DIXDC1 Promotes Lymphatic Metastasis and Resistance to Cuproptosis in Bladder Cancer Through Mediating DLAT. Advanced Science, 13(63). https://doi.org/10.1002/advs.77435
Vancouver
Li H, Cheng L, Lu X, Dong H, Fu S, Shi H, et al. DIXDC1 Promotes Lymphatic Metastasis and Resistance to Cuproptosis in Bladder Cancer Through Mediating DLAT. Advanced Science. 2026;13(63). doi:10.1002/advs.77435
BibTeX
@article{Li2026,
author = {Li, Hongqiong and Cheng, Liang and Lu, Xiaole and Dong, Haonan and Fu, Shi and Shi, Hongjin and Liu, Mingsheng and Yang, Chenwei and Huang, Yuhang and Chen, Zehua and Zhang, Yawei and Jie, Kaiwen and Zhang, Xiaoyue and Kui, Xiang and Ye, Xinni and Chen, Siting and Chen, Xu and Wang, Haifeng},
title = {DIXDC1 Promotes Lymphatic Metastasis and Resistance to Cuproptosis in Bladder Cancer Through Mediating DLAT},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {63},
doi = {10.1002/advs.77435}
}
EUVIMED